An Institutional Biosafety Committee (IBC) is required at all institutions that receive funding from the National Institutes of Health (NIH) for research involving recombinant DNA molecules. All recombinant DNA research or instructional activities at OSU-CHS, regardless of funding source, must be conducted in accordance with the NIH Guidelines for Research Involving Recombinant DNA Molecules and must be registered with the IBC.
The university IBC is further charged with reviewing and approving research and instructional activities conducted with microorganisms pathogenic to humans, plants, or animals. This review is conducted pursuant to the Centers for Disease Control and Prevention (CDC)/NIH publication, Biosafety in Microbiological and Biomedical Laboratories (currently in 5th edition, February 2007).
The IBC in conjunction with the Office of Research will also provide guidance to the OSU-CHS research community regarding proper acquisition, handling, transfer, and disposal of potentially hazardous or regulated biological materials.